Taidoc Technology Corp develops and manufactures blood glucose monitoring systems, blood pressure monitoring systems, blood glucose plus pressure monitoring systems, ear & forehead thermometers, and strip designing & processing, as well as advanced regulatory & business consulting services.

Announcement Of The Company'S
Investor Conference

Taidoc Board Of Directors Approved The
2025 Third Quater Consolidated Financial Statements

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Taidoc Technology (4736 TT)

Announcement Of The Company'S Investor Conference

Taidoc Board Of Directors Approved The 2025 Third Quater Consolidated Financial Statements

Announcement Of The Board Meeting Date Regarding The Company'S Consolidated Financial Report For The Third Quarter Of 2025

Announcement Of The Company'S Record Date For Distribution Of Cash

Disposal Of Securities.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)